The Joint Corp.
The Joint Corp. (JYNT) Stock Competitors & Peer Comparison
See (JYNT) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| JYNT | $11.40 | +0.35% | 174.1M | -113.80 | -$0.10 | N/A |
| HCA | $345.86 | +3.45% | 81.9B | 14.30 | $23.80 | +0.81% |
| FMS | $26.04 | -1.49% | 15.2B | 20.83 | $1.24 | +3.05% |
| THC | $158.36 | +3.49% | 14.5B | 9.83 | $15.91 | N/A |
| SOLV | $74.11 | -0.86% | 12.8B | 34.00 | $2.17 | N/A |
| DVA | $145.92 | +0.52% | 11B | 14.43 | $10.07 | N/A |
| EHC | $107.70 | +0.03% | 10.8B | 22.05 | $4.86 | +0.64% |
| UHS | $159.27 | +2.36% | 10B | 8.71 | $17.80 | +0.52% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| ENSG | $150.44 | +0.25% | 8.5B | 26.77 | $5.52 | +0.17% |
Stock Comparison
JYNT vs HCA Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, HCA has a market cap of 81.9B. Regarding current trading prices, JYNT is priced at $11.40, while HCA trades at $345.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas HCA's P/E ratio is 14.30. In terms of profitability, JYNT's ROE is -0.43%, compared to HCA's ROE of -2.11%. Regarding short-term risk, JYNT is less volatile compared to HCA. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check HCA's competition here
JYNT vs FMS Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, FMS has a market cap of 15.2B. Regarding current trading prices, JYNT is priced at $11.40, while FMS trades at $26.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas FMS's P/E ratio is 20.83. In terms of profitability, JYNT's ROE is -0.43%, compared to FMS's ROE of +0.04%. Regarding short-term risk, JYNT is more volatile compared to FMS. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check FMS's competition here
JYNT vs THC Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, THC has a market cap of 14.5B. Regarding current trading prices, JYNT is priced at $11.40, while THC trades at $158.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas THC's P/E ratio is 9.83. In terms of profitability, JYNT's ROE is -0.43%, compared to THC's ROE of +0.37%. Regarding short-term risk, JYNT is less volatile compared to THC. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check THC's competition here
JYNT vs SOLV Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, SOLV has a market cap of 12.8B. Regarding current trading prices, JYNT is priced at $11.40, while SOLV trades at $74.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas SOLV's P/E ratio is 34.00. In terms of profitability, JYNT's ROE is -0.43%, compared to SOLV's ROE of +0.12%. Regarding short-term risk, JYNT is more volatile compared to SOLV. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check SOLV's competition here
JYNT vs DVA Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, DVA has a market cap of 11B. Regarding current trading prices, JYNT is priced at $11.40, while DVA trades at $145.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas DVA's P/E ratio is 14.43. In terms of profitability, JYNT's ROE is -0.43%, compared to DVA's ROE of +3.94%. Regarding short-term risk, JYNT is more volatile compared to DVA. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check DVA's competition here
JYNT vs EHC Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, EHC has a market cap of 10.8B. Regarding current trading prices, JYNT is priced at $11.40, while EHC trades at $107.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas EHC's P/E ratio is 22.05. In terms of profitability, JYNT's ROE is -0.43%, compared to EHC's ROE of +0.25%. Regarding short-term risk, JYNT is more volatile compared to EHC. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check EHC's competition here
JYNT vs UHS Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, UHS has a market cap of 10B. Regarding current trading prices, JYNT is priced at $11.40, while UHS trades at $159.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas UHS's P/E ratio is 8.71. In terms of profitability, JYNT's ROE is -0.43%, compared to UHS's ROE of +0.18%. Regarding short-term risk, JYNT is less volatile compared to UHS. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check UHS's competition here
JYNT vs OSH Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, JYNT is priced at $11.40, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas OSH's P/E ratio is -17.65. In terms of profitability, JYNT's ROE is -0.43%, compared to OSH's ROE of +4.64%. Regarding short-term risk, JYNT is more volatile compared to OSH. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check OSH's competition here
JYNT vs ENSG Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, ENSG has a market cap of 8.5B. Regarding current trading prices, JYNT is priced at $11.40, while ENSG trades at $150.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas ENSG's P/E ratio is 26.77. In terms of profitability, JYNT's ROE is -0.43%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, JYNT is less volatile compared to ENSG. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check ENSG's competition here
JYNT vs CHE Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, JYNT is priced at $11.40, while CHE trades at $469.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas CHE's P/E ratio is 22.74. In terms of profitability, JYNT's ROE is -0.43%, compared to CHE's ROE of +0.26%. Regarding short-term risk, JYNT is more volatile compared to CHE. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check CHE's competition here
JYNT vs LHCG Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, JYNT is priced at $11.40, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas LHCG's P/E ratio is 82.83. In terms of profitability, JYNT's ROE is -0.43%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, JYNT is more volatile compared to LHCG. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check LHCG's competition here
JYNT vs OPCH Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, OPCH has a market cap of 4.9B. Regarding current trading prices, JYNT is priced at $11.40, while OPCH trades at $30.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas OPCH's P/E ratio is 23.82. In terms of profitability, JYNT's ROE is -0.43%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, JYNT is less volatile compared to OPCH. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check OPCH's competition here
JYNT vs AMED Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, AMED has a market cap of 3.2B. Regarding current trading prices, JYNT is priced at $11.40, while AMED trades at $97.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas AMED's P/E ratio is 35.76. In terms of profitability, JYNT's ROE is -0.43%, compared to AMED's ROE of +0.10%. Regarding short-term risk, JYNT is more volatile compared to AMED. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check AMED's competition here
JYNT vs SGRY Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, SGRY has a market cap of 2.9B. Regarding current trading prices, JYNT is priced at $11.40, while SGRY trades at $22.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas SGRY's P/E ratio is -14.67. In terms of profitability, JYNT's ROE is -0.43%, compared to SGRY's ROE of -0.10%. Regarding short-term risk, JYNT is less volatile compared to SGRY. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check SGRY's competition here
JYNT vs ACHC Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, ACHC has a market cap of 2.1B. Regarding current trading prices, JYNT is priced at $11.40, while ACHC trades at $22.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas ACHC's P/E ratio is 11.12. In terms of profitability, JYNT's ROE is -0.43%, compared to ACHC's ROE of +0.06%. Regarding short-term risk, JYNT is less volatile compared to ACHC. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check ACHC's competition here
JYNT vs ADUS Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, ADUS has a market cap of 2B. Regarding current trading prices, JYNT is priced at $11.40, while ADUS trades at $110.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas ADUS's P/E ratio is 24.69. In terms of profitability, JYNT's ROE is -0.43%, compared to ADUS's ROE of +0.08%. Regarding short-term risk, JYNT is less volatile compared to ADUS. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check ADUS's competition here
JYNT vs AMEH Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, JYNT is priced at $11.40, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas AMEH's P/E ratio is 39.25. In terms of profitability, JYNT's ROE is -0.43%, compared to AMEH's ROE of +0.07%. Regarding short-term risk, JYNT is less volatile compared to AMEH. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check AMEH's competition here
JYNT vs SEM Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, SEM has a market cap of 1.8B. Regarding current trading prices, JYNT is priced at $11.40, while SEM trades at $14.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas SEM's P/E ratio is 22.82. In terms of profitability, JYNT's ROE is -0.43%, compared to SEM's ROE of +0.10%. Regarding short-term risk, JYNT is less volatile compared to SEM. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check SEM's competition here
JYNT vs BKD Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, BKD has a market cap of 1.8B. Regarding current trading prices, JYNT is priced at $11.40, while BKD trades at $7.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas BKD's P/E ratio is -7.20. In terms of profitability, JYNT's ROE is -0.43%, compared to BKD's ROE of -0.96%. Regarding short-term risk, JYNT is less volatile compared to BKD. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check BKD's competition here
JYNT vs LFST Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, LFST has a market cap of 1.6B. Regarding current trading prices, JYNT is priced at $11.40, while LFST trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas LFST's P/E ratio is -46.33. In terms of profitability, JYNT's ROE is -0.43%, compared to LFST's ROE of -0.02%. Regarding short-term risk, JYNT is less volatile compared to LFST. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check LFST's competition here
JYNT vs ARDT Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, ARDT has a market cap of 1.5B. Regarding current trading prices, JYNT is priced at $11.40, while ARDT trades at $10.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas ARDT's P/E ratio is 6.35. In terms of profitability, JYNT's ROE is -0.43%, compared to ARDT's ROE of +0.24%. Regarding short-term risk, JYNT is less volatile compared to ARDT. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check ARDT's competition here
JYNT vs NHC Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, NHC has a market cap of 1.5B. Regarding current trading prices, JYNT is priced at $11.40, while NHC trades at $96.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas NHC's P/E ratio is 13.91. In terms of profitability, JYNT's ROE is -0.43%, compared to NHC's ROE of +0.11%. Regarding short-term risk, JYNT is more volatile compared to NHC. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check NHC's competition here
JYNT vs BKDT Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, JYNT is priced at $11.40, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas BKDT's P/E ratio is N/A. In terms of profitability, JYNT's ROE is -0.43%, compared to BKDT's ROE of -0.96%. Regarding short-term risk, JYNT is more volatile compared to BKDT. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check BKDT's competition here
JYNT vs ASTH Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, ASTH has a market cap of 1.2B. Regarding current trading prices, JYNT is priced at $11.40, while ASTH trades at $23.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas ASTH's P/E ratio is 32.41. In terms of profitability, JYNT's ROE is -0.43%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, JYNT is more volatile compared to ASTH. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check ASTH's competition here
JYNT vs USPH Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, USPH has a market cap of 1.1B. Regarding current trading prices, JYNT is priced at $11.40, while USPH trades at $76.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas USPH's P/E ratio is 34.59. In terms of profitability, JYNT's ROE is -0.43%, compared to USPH's ROE of +0.06%. Regarding short-term risk, JYNT is more volatile compared to USPH. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check USPH's competition here
JYNT vs MD Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, MD has a market cap of 1.1B. Regarding current trading prices, JYNT is priced at $11.40, while MD trades at $12.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas MD's P/E ratio is -12.66. In terms of profitability, JYNT's ROE is -0.43%, compared to MD's ROE of -0.11%. Regarding short-term risk, JYNT and MD have similar daily volatility (1.38).Check MD's competition here
JYNT vs HCSG Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, HCSG has a market cap of 966.2M. Regarding current trading prices, JYNT is priced at $11.40, while HCSG trades at $13.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas HCSG's P/E ratio is 94.64. In terms of profitability, JYNT's ROE is -0.43%, compared to HCSG's ROE of +0.02%. Regarding short-term risk, JYNT is less volatile compared to HCSG. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check HCSG's competition here
JYNT vs AGL Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, AGL has a market cap of 825.8M. Regarding current trading prices, JYNT is priced at $11.40, while AGL trades at $2.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas AGL's P/E ratio is -3.22. In terms of profitability, JYNT's ROE is -0.43%, compared to AGL's ROE of -0.44%. Regarding short-term risk, JYNT is less volatile compared to AGL. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check AGL's competition here
JYNT vs PNTG Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, PNTG has a market cap of 800.4M. Regarding current trading prices, JYNT is priced at $11.40, while PNTG trades at $23.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas PNTG's P/E ratio is 30.55. In terms of profitability, JYNT's ROE is -0.43%, compared to PNTG's ROE of +0.11%. Regarding short-term risk, JYNT is less volatile compared to PNTG. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check PNTG's competition here
JYNT vs AVAH Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, AVAH has a market cap of 770.6M. Regarding current trading prices, JYNT is priced at $11.40, while AVAH trades at $4.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas AVAH's P/E ratio is 131.67. In terms of profitability, JYNT's ROE is -0.43%, compared to AVAH's ROE of -0.12%. Regarding short-term risk, JYNT is less volatile compared to AVAH. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check AVAH's competition here
JYNT vs AMN Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, AMN has a market cap of 753.1M. Regarding current trading prices, JYNT is priced at $11.40, while AMN trades at $19.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas AMN's P/E ratio is -4.54. In terms of profitability, JYNT's ROE is -0.43%, compared to AMN's ROE of -0.21%. Regarding short-term risk, JYNT is less volatile compared to AMN. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check AMN's competition here
JYNT vs INNV Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, INNV has a market cap of 506.3M. Regarding current trading prices, JYNT is priced at $11.40, while INNV trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas INNV's P/E ratio is -15.62. In terms of profitability, JYNT's ROE is -0.43%, compared to INNV's ROE of -0.12%. Regarding short-term risk, JYNT is less volatile compared to INNV. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check INNV's competition here
JYNT vs SNDA Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, SNDA has a market cap of 466.4M. Regarding current trading prices, JYNT is priced at $11.40, while SNDA trades at $25.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas SNDA's P/E ratio is -6.81. In terms of profitability, JYNT's ROE is -0.43%, compared to SNDA's ROE of -0.53%. Regarding short-term risk, JYNT is less volatile compared to SNDA. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check SNDA's competition here
JYNT vs AUNA Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, AUNA has a market cap of 457.4M. Regarding current trading prices, JYNT is priced at $11.40, while AUNA trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas AUNA's P/E ratio is 9.36. In terms of profitability, JYNT's ROE is -0.43%, compared to AUNA's ROE of +0.11%. Regarding short-term risk, JYNT is more volatile compared to AUNA. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check AUNA's competition here
JYNT vs CCRN Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, CCRN has a market cap of 452.7M. Regarding current trading prices, JYNT is priced at $11.40, while CCRN trades at $13.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas CCRN's P/E ratio is -25.57. In terms of profitability, JYNT's ROE is -0.43%, compared to CCRN's ROE of -0.04%. Regarding short-term risk, JYNT is less volatile compared to CCRN. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check CCRN's competition here
JYNT vs TALKW Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, TALKW has a market cap of 430.2M. Regarding current trading prices, JYNT is priced at $11.40, while TALKW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas TALKW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is -0.43%, compared to TALKW's ROE of -0.04%. Regarding short-term risk, JYNT is less volatile compared to TALKW. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check TALKW's competition here
JYNT vs TALK Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, TALK has a market cap of 428.3M. Regarding current trading prices, JYNT is priced at $11.40, while TALK trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas TALK's P/E ratio is 128.00. In terms of profitability, JYNT's ROE is -0.43%, compared to TALK's ROE of -0.04%. Regarding short-term risk, JYNT is less volatile compared to TALK. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check TALK's competition here
JYNT vs CMPS Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, CMPS has a market cap of 406.1M. Regarding current trading prices, JYNT is priced at $11.40, while CMPS trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas CMPS's P/E ratio is -2.18. In terms of profitability, JYNT's ROE is -0.43%, compared to CMPS's ROE of -0.72%. Regarding short-term risk, JYNT is less volatile compared to CMPS. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check CMPS's competition here
JYNT vs AIRS Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, AIRS has a market cap of 395.4M. Regarding current trading prices, JYNT is priced at $11.40, while AIRS trades at $6.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas AIRS's P/E ratio is -21.84. In terms of profitability, JYNT's ROE is -0.43%, compared to AIRS's ROE of -0.21%. Regarding short-term risk, JYNT is less volatile compared to AIRS. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check AIRS's competition here
JYNT vs CYH Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, CYH has a market cap of 362.2M. Regarding current trading prices, JYNT is priced at $11.40, while CYH trades at $2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas CYH's P/E ratio is -1.76. In terms of profitability, JYNT's ROE is -0.43%, compared to CYH's ROE of +0.11%. Regarding short-term risk, JYNT is less volatile compared to CYH. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check CYH's competition here
JYNT vs TOIIW Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, TOIIW has a market cap of 357.6M. Regarding current trading prices, JYNT is priced at $11.40, while TOIIW trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas TOIIW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is -0.43%, compared to TOIIW's ROE of -4.83%. Regarding short-term risk, JYNT is less volatile compared to TOIIW. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check TOIIW's competition here
JYNT vs TOI Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, TOI has a market cap of 346.5M. Regarding current trading prices, JYNT is priced at $11.40, while TOI trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas TOI's P/E ratio is -5.39. In terms of profitability, JYNT's ROE is -0.43%, compared to TOI's ROE of -4.83%. Regarding short-term risk, JYNT is less volatile compared to TOI. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check TOI's competition here
JYNT vs EHAB Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, EHAB has a market cap of 344.1M. Regarding current trading prices, JYNT is priced at $11.40, while EHAB trades at $6.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas EHAB's P/E ratio is -2.45. In terms of profitability, JYNT's ROE is -0.43%, compared to EHAB's ROE of -0.31%. Regarding short-term risk, JYNT is less volatile compared to EHAB. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check EHAB's competition here
JYNT vs AONC Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, AONC has a market cap of 299M. Regarding current trading prices, JYNT is priced at $11.40, while AONC trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas AONC's P/E ratio is -11.52. In terms of profitability, JYNT's ROE is -0.43%, compared to AONC's ROE of +0.25%. Regarding short-term risk, JYNT is more volatile compared to AONC. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check AONC's competition here
JYNT vs CSU Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, JYNT is priced at $11.40, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas CSU's P/E ratio is 0.67. In terms of profitability, JYNT's ROE is -0.43%, compared to CSU's ROE of +2.23%. Regarding short-term risk, JYNT is less volatile compared to CSU. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check CSU's competition here
JYNT vs BTMD Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, BTMD has a market cap of 167.3M. Regarding current trading prices, JYNT is priced at $11.40, while BTMD trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas BTMD's P/E ratio is 7.53. In terms of profitability, JYNT's ROE is -0.43%, compared to BTMD's ROE of -0.19%. Regarding short-term risk, JYNT is less volatile compared to BTMD. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check BTMD's competition here
JYNT vs DCGO Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, DCGO has a market cap of 147.7M. Regarding current trading prices, JYNT is priced at $11.40, while DCGO trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas DCGO's P/E ratio is -149.00. In terms of profitability, JYNT's ROE is -0.43%, compared to DCGO's ROE of -0.00%. Regarding short-term risk, JYNT is less volatile compared to DCGO. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check DCGO's competition here
JYNT vs FVE Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, JYNT is priced at $11.40, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas FVE's P/E ratio is -5.64. In terms of profitability, JYNT's ROE is -0.43%, compared to FVE's ROE of -0.15%. Regarding short-term risk, JYNT is less volatile compared to FVE. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check FVE's competition here
JYNT vs KDLYW Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, JYNT is priced at $11.40, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas KDLYW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is -0.43%, compared to KDLYW's ROE of -1.46%. Regarding short-term risk, JYNT is less volatile compared to KDLYW. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check KDLYW's competition here
JYNT vs MODV Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, MODV has a market cap of 44.2M. Regarding current trading prices, JYNT is priced at $11.40, while MODV trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas MODV's P/E ratio is -0.19. In terms of profitability, JYNT's ROE is -0.43%, compared to MODV's ROE of +6.87%. Regarding short-term risk, JYNT is less volatile compared to MODV. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check MODV's competition here
JYNT vs ALR Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, JYNT is priced at $11.40, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas ALR's P/E ratio is -1.11. In terms of profitability, JYNT's ROE is -0.43%, compared to ALR's ROE of -0.15%. Regarding short-term risk, JYNT is more volatile compared to ALR. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check ALR's competition here
JYNT vs CCEL Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, CCEL has a market cap of 39.6M. Regarding current trading prices, JYNT is priced at $11.40, while CCEL trades at $4.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas CCEL's P/E ratio is -246.00. In terms of profitability, JYNT's ROE is -0.43%, compared to CCEL's ROE of +0.01%. Regarding short-term risk, JYNT is less volatile compared to CCEL. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check CCEL's competition here
JYNT vs IMAC Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, JYNT is priced at $11.40, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas IMAC's P/E ratio is -2.27. In terms of profitability, JYNT's ROE is -0.43%, compared to IMAC's ROE of -0.78%. Regarding short-term risk, JYNT is less volatile compared to IMAC. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check IMAC's competition here
JYNT vs PIII Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, PIII has a market cap of 22.9M. Regarding current trading prices, JYNT is priced at $11.40, while PIII trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas PIII's P/E ratio is -0.13. In terms of profitability, JYNT's ROE is -0.43%, compared to PIII's ROE of -1.29%. Regarding short-term risk, JYNT is less volatile compared to PIII. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check PIII's competition here
JYNT vs AMS Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, AMS has a market cap of 16.6M. Regarding current trading prices, JYNT is priced at $11.40, while AMS trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas AMS's P/E ratio is 12.29. In terms of profitability, JYNT's ROE is -0.43%, compared to AMS's ROE of +0.06%. Regarding short-term risk, JYNT is less volatile compared to AMS. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check AMS's competition here
JYNT vs AIH Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, JYNT is priced at $11.40, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas AIH's P/E ratio is -2.78. In terms of profitability, JYNT's ROE is -0.43%, compared to AIH's ROE of +1.16%. Regarding short-term risk, JYNT is less volatile compared to AIH. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check AIH's competition here
JYNT vs CANO Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, JYNT is priced at $11.40, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas CANO's P/E ratio is -0.01. In terms of profitability, JYNT's ROE is -0.43%, compared to CANO's ROE of -1.49%. Regarding short-term risk, JYNT is less volatile compared to CANO. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check CANO's competition here
JYNT vs FTRP Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, JYNT is priced at $11.40, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas FTRP's P/E ratio is -1.22. In terms of profitability, JYNT's ROE is -0.43%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, JYNT is less volatile compared to FTRP. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check FTRP's competition here
JYNT vs GBNH Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, JYNT is priced at $11.40, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas GBNH's P/E ratio is -0.06. In terms of profitability, JYNT's ROE is -0.43%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, JYNT is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check GBNH's competition here
JYNT vs RHE Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, JYNT is priced at $11.40, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas RHE's P/E ratio is -1.79. In terms of profitability, JYNT's ROE is -0.43%, compared to RHE's ROE of +1.52%. Regarding short-term risk, JYNT is less volatile compared to RHE. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check RHE's competition here
JYNT vs MNDR Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, MNDR has a market cap of 4.6M. Regarding current trading prices, JYNT is priced at $11.40, while MNDR trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas MNDR's P/E ratio is -0.15. In terms of profitability, JYNT's ROE is -0.43%, compared to MNDR's ROE of -5.70%. Regarding short-term risk, JYNT is less volatile compared to MNDR. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check MNDR's competition here
JYNT vs ATIP Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, ATIP has a market cap of 3M. Regarding current trading prices, JYNT is priced at $11.40, while ATIP trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas ATIP's P/E ratio is -0.03. In terms of profitability, JYNT's ROE is -0.43%, compared to ATIP's ROE of +1.77%. Regarding short-term risk, JYNT is less volatile compared to ATIP. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check ATIP's competition here
JYNT vs NIVFW Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, NIVFW has a market cap of 2.4M. Regarding current trading prices, JYNT is priced at $11.40, while NIVFW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas NIVFW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is -0.43%, compared to NIVFW's ROE of -0.39%. Regarding short-term risk, JYNT is less volatile compared to NIVFW. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check NIVFW's competition here
JYNT vs IONM Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, IONM has a market cap of 2M. Regarding current trading prices, JYNT is priced at $11.40, while IONM trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas IONM's P/E ratio is N/A. In terms of profitability, JYNT's ROE is -0.43%, compared to IONM's ROE of +0.75%. Regarding short-term risk, JYNT is less volatile compared to IONM. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check IONM's competition here
JYNT vs IMACW Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, JYNT is priced at $11.40, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas IMACW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is -0.43%, compared to IMACW's ROE of +2.05%. Regarding short-term risk, JYNT is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check IMACW's competition here
JYNT vs SYRA Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, SYRA has a market cap of 1.2M. Regarding current trading prices, JYNT is priced at $11.40, while SYRA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas SYRA's P/E ratio is -0.31. In terms of profitability, JYNT's ROE is -0.43%, compared to SYRA's ROE of -1.04%. Regarding short-term risk, JYNT is more volatile compared to SYRA. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check SYRA's competition here
JYNT vs CCM Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, CCM has a market cap of 885.3K. Regarding current trading prices, JYNT is priced at $11.40, while CCM trades at $5.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas CCM's P/E ratio is -0.55. In terms of profitability, JYNT's ROE is -0.43%, compared to CCM's ROE of +0.08%. Regarding short-term risk, JYNT is less volatile compared to CCM. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check CCM's competition here
JYNT vs RHE-PA Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, RHE-PA has a market cap of 674.5K. Regarding current trading prices, JYNT is priced at $11.40, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, JYNT's ROE is -0.43%, compared to RHE-PA's ROE of +1.52%. Regarding short-term risk, JYNT is less volatile compared to RHE-PA. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check RHE-PA's competition here
JYNT vs BACK Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, BACK has a market cap of 227.1K. Regarding current trading prices, JYNT is priced at $11.40, while BACK trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas BACK's P/E ratio is -0.01. In terms of profitability, JYNT's ROE is -0.43%, compared to BACK's ROE of +2.05%. Regarding short-term risk, JYNT is more volatile compared to BACK. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check BACK's competition here
JYNT vs NVOS Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, NVOS has a market cap of 65.1K. Regarding current trading prices, JYNT is priced at $11.40, while NVOS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas NVOS's P/E ratio is N/A. In terms of profitability, JYNT's ROE is -0.43%, compared to NVOS's ROE of -1.20%. Regarding short-term risk, JYNT is more volatile compared to NVOS. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check NVOS's competition here
JYNT vs PIIIW Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, PIIIW has a market cap of 33K. Regarding current trading prices, JYNT is priced at $11.40, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas PIIIW's P/E ratio is -0.01. In terms of profitability, JYNT's ROE is -0.43%, compared to PIIIW's ROE of -1.29%. Regarding short-term risk, JYNT is more volatile compared to PIIIW. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check PIIIW's competition here
JYNT vs DCGOW Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, JYNT is priced at $11.40, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas DCGOW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is -0.43%, compared to DCGOW's ROE of -0.00%. Regarding short-term risk, JYNT is less volatile compared to DCGOW. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check DCGOW's competition here
JYNT vs TLMD Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, TLMD has a market cap of 0. Regarding current trading prices, JYNT is priced at $11.40, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas TLMD's P/E ratio is -1.60. In terms of profitability, JYNT's ROE is -0.43%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, JYNT is more volatile compared to TLMD. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check TLMD's competition here
JYNT vs TVTY Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, TVTY has a market cap of 0. Regarding current trading prices, JYNT is priced at $11.40, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas TVTY's P/E ratio is 19.06. In terms of profitability, JYNT's ROE is -0.43%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, JYNT is more volatile compared to TVTY. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check TVTY's competition here
JYNT vs TLMDW Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, JYNT is priced at $11.40, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas TLMDW's P/E ratio is N/A. In terms of profitability, JYNT's ROE is -0.43%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, JYNT is less volatile compared to TLMDW. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check TLMDW's competition here
JYNT vs DVCR Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, DVCR has a market cap of 0. Regarding current trading prices, JYNT is priced at $11.40, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas DVCR's P/E ratio is 28.34. In terms of profitability, JYNT's ROE is -0.43%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, JYNT is more volatile compared to DVCR. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check DVCR's competition here
JYNT vs NFH Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, NFH has a market cap of 0. Regarding current trading prices, JYNT is priced at $11.40, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas NFH's P/E ratio is -19.75. In terms of profitability, JYNT's ROE is -0.43%, compared to NFH's ROE of -0.06%. Regarding short-term risk, JYNT is more volatile compared to NFH. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check NFH's competition here
JYNT vs SLHG Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, SLHG has a market cap of 0. Regarding current trading prices, JYNT is priced at $11.40, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas SLHG's P/E ratio is -1.48. In terms of profitability, JYNT's ROE is -0.43%, compared to SLHG's ROE of N/A. Regarding short-term risk, JYNT is less volatile compared to SLHG. This indicates potentially lower risk in terms of short-term price fluctuations for JYNT.Check SLHG's competition here
JYNT vs HNGR Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, HNGR has a market cap of 0. Regarding current trading prices, JYNT is priced at $11.40, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas HNGR's P/E ratio is 19.71. In terms of profitability, JYNT's ROE is -0.43%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, JYNT is more volatile compared to HNGR. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check HNGR's competition here
JYNT vs SLHGP Comparison July 2025
JYNT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JYNT stands at 174.1M. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, JYNT is priced at $11.40, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JYNT currently has a P/E ratio of -113.80, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, JYNT's ROE is -0.43%, compared to SLHGP's ROE of -0.71%. Regarding short-term risk, JYNT is more volatile compared to SLHGP. This indicates potentially higher risk in terms of short-term price fluctuations for JYNT.Check SLHGP's competition here